Last10K.com

Lava Medtech Acquisition Corp. (LVAC) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

LVAC Quarterly Reports

    10-Q Quarterly Report August 2022
  • 10-Q Quarterly Report May 2022

Lava Medtech Acquisition Corp.

CIK: 1855450 Ticker: LVAC
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 16, 2022
Document Information Line Items  
Entity Registrant NameLAVAMEDTECH ACQUISITION CORP. 
Trading SymbolLVAC 
Document Type10-Q 
Current Fiscal Year End Date--12-31 
Amendment Flagfalse 
Entity Central Index Key0001855450 
Entity Current Reporting StatusYes 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateMar. 31, 2022 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Entity Shell Companytrue 
Entity Ex Transition Periodfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number001-40965 
Entity Incorporation, State or Country CodeDE 
Entity Tax Identification Number86-2973712 
Entity Address, Address Line One303 Wyman Street 
Entity Address, Address Line TwoSuite 300 
Entity Address, City or TownWaltham 
Entity Address, State or ProvinceMA 
Entity Address, Postal Zip Code02451 
City Area Code(781) 
Local Phone Number530-3868 
Title of 12(b) SecurityShares of Class A common stock, par value $0.0001 per share, included as part of the units 
Security Exchange NameNASDAQ 
Entity Interactive Data CurrentYes 
Class A Common Stock  
Document Information Line Items  
Entity Common Stock, Shares Outstanding 11,500,000
Class B Common Stock  
Document Information Line Items  
Entity Common Stock, Shares Outstanding 2,875,000

View differences made from one quarter to another to evaluate Lava Medtech Acquisition Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Lava Medtech Acquisition Corp..

Continue

Assess how Lava Medtech Acquisition Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Lava Medtech Acquisition Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Balance Sheets
Condensed Balance Sheets (Parentheticals)
Condensed Statement Of Changes In Stockholders??? Deficit (Unaudited)
Condensed Statements Of Cash Flows (Unaudited)
Condensed Statements Of Operations (Unaudited)
Accounting Policies, By Policy (Policies)
Commitments And Contingencies
Commitments And Contingencies (Details)
Description Of Organization And Business Operations
Description Of Organization And Business Operations (Details)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Details) - Schedule Of Changes In The Fair Value Of Level 3 Warrant Liabilities
Fair Value Measurements (Details) - Schedule Of Fair Value Hierarchy Of The Valuation Inputs
Fair Value Measurements (Details) - Schedule Of Quantitative Information Regarding Level 3 Fair Value Measurements
Fair Value Measurements (Tables)
Initial Public Offering
Initial Public Offering (Details)
Private Placement Warrants
Private Placement Warrants (Details)
Related-Party Transactions
Related-Party Transactions (Details)
Stockholders??? Equity (Deficit)
Stockholders??? Equity (Deficit) (Details)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Details) - Schedule Of Basic And Diluted Net Loss Per Share
Summary Of Significant Accounting Policies (Details) - Schedule Of Benefit For Income Taxes
Summary Of Significant Accounting Policies (Details) - Schedule Of Class A Common Stock Reflected On The Balance Sheet
Summary Of Significant Accounting Policies (Details) - Schedule Of Deferred Tax Assets And Liabilities
Summary Of Significant Accounting Policies (Details) - Schedule Of Reconciliation Of The Statutory Federal Income Tax Rate
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

Lava Medtech Acquisition Corp. provided additional information to their SEC Filing as exhibits

Ticker: LVAC
CIK: 1855450
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-22-027078
Submitted to the SEC: Mon May 16 2022 4:04:34 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Blank Checks

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/lvac/0001213900-22-027078.htm